MOMA Therapeutics and Roche collaborate on critical cancer dependencies
The partnership capitalises on MOMA's KnowledgeBase platform to pinpoint and advance novel precision oncology targets characterised by high…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
05 Jan 24
The partnership capitalises on MOMA's KnowledgeBase platform to pinpoint and advance novel precision oncology targets characterised by high…
05 Jan 24
The partnership intends to combine Umoja's proprietary VivoVec gene delivery platform with AbbVie's expertise in oncology to develop…
05 Jan 24
Paragon Healthcare, headquartered in Plano, Texas, offers infusion services to patients via its omnichannel model of ambulatory infusion…
05 Jan 24
Under the agreement, Rhythm will pay $20m in Rhythm shares, $40m in cash to LG Chem at closing,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
05 Jan 24
The latest issue of the Seafood Processing Standard (SPS), which adopted a new format from the previous issue…
05 Jan 24
The new four-story 20,000 m² facility will feature mammalian cell culture, messenger RNA and cell therapy services and…
05 Jan 24
QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced a strategic plan to step up investments over the…
05 Jan 24
IFE Manufacturing, IFE, The Pub Show, HRC and International Salon Culinaire have joined forces under a new over-arching…
05 Jan 24
Most comprehensive and ethnically diverse genomic coverage on a high throughput microarray delivers multi-disease and pharmacogenomic research analysis…
05 Jan 24
Funding allows advancement of diverse programs through multiple clinical data readouts, including multiple indications for lead candidate felzartamab